Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Cell Reports. Medicine
|
August 26, 2025
An age-related decrease in leptin contributes to CD8<sup>+</sup> T cell aging in the tumor microenvironment
Feixiang Wang, Rujuan Bao, Shuiyu Xu, et al.
Nature Communications
|
April 2, 2022
Single-cell and spatial analysis reveal interaction of FAP<sup>+</sup> fibroblasts and SPP1<sup>+</sup> macrophages in colorectal cancer
Jingjing Qi, Hongxiang Sun, Yao Zhang, et al.
Innovation (Cambridge (Mass.))
|
January 3, 2022
Profiling of immune features to predict immunotherapy efficacy
Youqiong Ye, Yongchang Zhang, Nong Yang, et al.
Journal of Hepatology
|
January 28, 2023
Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy
Yao Liu, Zhenzhen Xun, Kun Ma, et al.
Cancer Cell
|
August 8, 2025
A pan-KRAS inhibitor and its derived degrader elicit multifaceted anti-tumor efficacy in KRAS-driven cancers
Juanjuan Feng, Xuanzheng Xiao, Xinting Xia, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Cell Reports. Medicine
|
August 26, 2025
An age-related decrease in leptin contributes to CD8<sup>+</sup> T cell aging in the tumor microenvironment
Feixiang Wang, Rujuan Bao, Shuiyu Xu, et al.
Nature Communications
|
April 2, 2022
Single-cell and spatial analysis reveal interaction of FAP<sup>+</sup> fibroblasts and SPP1<sup>+</sup> macrophages in colorectal cancer
Jingjing Qi, Hongxiang Sun, Yao Zhang, et al.
Innovation (Cambridge (Mass.))
|
January 3, 2022
Profiling of immune features to predict immunotherapy efficacy
Youqiong Ye, Yongchang Zhang, Nong Yang, et al.
Journal of Hepatology
|
January 28, 2023
Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy
Yao Liu, Zhenzhen Xun, Kun Ma, et al.
Cancer Cell
|
August 8, 2025
A pan-KRAS inhibitor and its derived degrader elicit multifaceted anti-tumor efficacy in KRAS-driven cancers
Juanjuan Feng, Xuanzheng Xiao, Xinting Xia, et al.
Page
of 2